The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial
Recruiting
N/A
Interventional Study
Endometriosis
Probiotics
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 35
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- The Gut Microbiome Center (Centar za crijevni mikrobiom) · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
ProMetrioS is a randomised blinded placebo-controlled cross-over trial investigating the effect of specific multistrain probiotics in patients with endometriosis. The aim of this clinical trial is to determine whether probiotic treatment can significantly modulate gut microbiome composition and functionality in endometriosis patients, specifically parameters associated with the estrobolome.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Minimum Age: - Maximum Age: 35 Years Sex: Female Gender Based: Ye - only women can participate in this study Accepts Healthy Volunteers: No
Inclusion Criteria:
* adult subjects with stage III or IV endometriosis diagnosis confirmed by biopsy
Exclusion Criteria:
* Age \> 35 years
* Immunocompromi…
Contacts